GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of MYX.AX
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Mayne Pharma Group Limited stock price down 2.06% on Wednesday
(Updated on Apr 17, 2024)

Sell candidate since Apr 16, 2024 Loss -2.06% PDF

The Mayne Pharma Group Limited stock price fell by -2.06% on the last day (Wednesday, 17th Apr 2024) from $6.80 to $6.66. It has now fallen 5 days in a row. During the last trading day the stock fluctuated 2.72% from a day low at $6.61 to a day high of $6.79. The price has fallen in 6 of the last 10 days and is down by -6.06% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -229 thousand shares and in total, 80 thousand shares were bought and sold for approximately $529.86 thousand.

Given the current short-term trend, the stock is expected to rise 48.75% during the next 3 months and, with a 90% probability hold a price between $9.91 and $11.46 at the end of this 3-month period.

Check out how to make money doing surveys! Ad

MYX.AX Signals & Forecast

There are few to no technical positive signals at the moment. The Mayne Pharma Group Limited stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $6.99 and $6.97. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, April 02, 2024, and so far it has fallen -8.14%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for Mayne Pharma Group Limited stock

Mayne Pharma Group Limited finds support from accumulated volume at $6.38 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have controlled movements and therefore the general risk is considered low. However, be aware of low or falling volume and make sure to keep an eye on the stock. During the last day, the stock moved $0.180 between high and low, or 2.72%. For the last week the stock has had daily average volatility of 2.79%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (MYX.AX) For The Upcoming Trading Day Of Thursday 18th

For the upcoming trading day on Thursday, 18th we expect Mayne Pharma Group Limited to open at $6.69, and during the day (based on 14 day Average True Range), to move between $6.43 and $6.89, which gives a possible trading interval of +/-$0.234 (+/-3.51%) up or down from last closing price. If Mayne Pharma Group Limited takes out the full calculated possible swing range there will be an estimated 7.01% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $6.80 (2.10%) than the support at $6.38 (4.20%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Mayne Pharma Group Limited stock A Buy?

The Mayne Pharma Group Limited stock holds several negative signals and despite the positive trend, we believe Mayne Pharma Group Limited will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -2.977 Sell Candidate Unchanged

Predicted Opening Price for Mayne Pharma Group Limited of Thursday, April 18, 2024

Fair opening price April 18, 2024 Current price
$6.69 ( 0.400%) $6.66

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for MYX.AX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 6.87 3.10 %
R2 6.80 2.07 %
R1 6.76 1.43 %
Current price: 6.66
Support S1 6.62 -0.632 %
S2 6.58 -1.27 %
S3 6.51 -2.30 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 7.19 7.96 %
R2 7.00 5.11 %
R1 6.80 2.10 %
Current price 6.66
Support S1 6.38 -4.20%
S2 6.03 -9.46%
S3 5.31 -20.27%

MYX Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Jan 18, 2023 Jan 18, 2023 Jan 18, 2023 $0.544 12.09%
2 Feb 25, 2011 Mar 03, 2011 Mar 25, 2011 $0.143 1.43%
3 Aug 31, 2010 Oct 25, 2010 Nov 18, 2010 $0.287 2.98%

FAQ

What is the symbol for Mayne Pharma Group Limited Stock and on which exchange is it traded?
The symbol for Mayne Pharma Group Limited is MYX.AX and it is traded on the ASX (Australian Securities Exchange).

Should I buy or sell Mayne Pharma Group Limited Stock?
The Mayne Pharma Group Limited stock holds several negative signals and despite the positive trend, we believe Mayne Pharma Group Limited will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Mayne Pharma Group Limited Stock?
Mayne Pharma Group Limited Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Mayne Pharma Group Limited Stock.

What's the current price of Mayne Pharma Group Limited Stock?
As of the end of day on the 2024-04-17, the price of an Mayne Pharma Group Limited (MYX.AX) share was $6.66.

What is the 52-week high and low for Mayne Pharma Group Limited Stock?
The 52-week high for Mayne Pharma Group Limited Stock is $7.40 and the 52-week low is $2.75.

What is the market capitalization of Mayne Pharma Group Limited Stock?
As of the 2024-04-17, the market capitalization of Mayne Pharma Group Limited is 578.505M.

When is the next earnings date for Mayne Pharma Group Limited?
The upcoming earnings date for Mayne Pharma Group Limited is Aug 30, 2024.
Click to get the best stock tips daily for free!

About Mayne Pharma Group Limited

Mayne Pharma Group Limited Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, the United States, Asia, and internationally. The company operates through four segments: Generic Products, Specialty Products, Metrics Contract Services, and Mayne Pharma International. It provides oral drug delivery systems; and contract pharmaceutical development, manufacturing, and analytical service... MYX.AX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT